Nabity-Jensen Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Hold
1,660
– – 1.22% 22
2026
Q1
$1.53M Buy
1,660
+194
+13% +$197K 1.06% 23
2025
Q4
$1.58M Buy
1,466
+53
+4% +$50.7K 1.07% 23
2025
Q3
$1.08M Buy
1,413
+18
+1% +$13.4K 0.75% 27
2025
Q2
$1.09M Buy
1,395
+4
+0.3% +$3.11K 0.8% 27
2025
Q1
$1.15M Buy
1,391
+22
+2% +$18.3K 0.91% 26
2024
Q4
$1.06M Buy
1,369
+164
+14% +$136K 0.8% 28
2024
Q3
$1.07M Buy
1,205
+113
+10% +$102K 0.82% 28
2024
Q2
$989K Buy
1,092
+110
+11% +$88K 0.81% 27
2024
Q1
$764K Buy
982
+25
+3% +$17.8K 0.63% 33
2023
Q4
$558K Buy
+957
New +$559K 0.5% 38

Other funds holding LLY

Nabity-Jensen Investment Management's LLY Position: Q2 2026 in Review

Nabity-Jensen Investment Management held its Eli Lilly (LLY) position steady in Q2 2026 at 1,660 shares worth $1.99M. The position accounts for 1.22% of the portfolio, ranked #22.

Nabity-Jensen Investment Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nabity-Jensen Investment Management held 1,660 shares of Eli Lilly worth $1.99M as of Q2 2026.
  • Nabity-Jensen Investment Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.22% of Nabity-Jensen Investment Management's portfolio in Q2 2026, its #22 holding.
  • Nabity-Jensen Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nabity-Jensen Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.